Granules India share price

ABOUT Granules India

• Industry Biotechnology & Drugs
• ISIN INE101D01020
• BSE Code 532482
• NSE Code GRANULES

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical’s products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over seven manufacturing facilities, approximately six of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

Granules India Management

• Krishna Chigurupati Executive Chairman of the Board, Managing Director
• Kandiraju Rao Chief Executive Officer, Joint Managing Director, Executive Director
• Mukesh Surana Chief Financial Officer
• Anil Arora Corporate Executive
• Atul Dhavle Chief Human Resource Officer
• Sanjay Kumar Senior Vice President - Corporate Strategy & Planning
• G. N. Prashanth Senior Vice President & Head Corporate Quality
• Manikandan Ramalingam Senior Vice President & Head Formulation R&D
• Sethu Sankaran Senior Vice President - API Manufacturing & Operations
• Chaitanya Tummala Compliance Officer, Company Secretary